Description
Dihydroboldenone cypionate, commonly referred to as DHB, is an anabolic steroid that is primarily researched for its potential to promote muscle growth and enhance athletic performance. It is a derivative of boldenone, modified to increase its anabolic properties while reducing androgenic effects. DHB is typically administered via intramuscular injection.
Side effects of DHB may include symptoms of masculinization such as acne, increased body hair, voice changes, and alterations in libido. As a potent anabolic agent, DHB acts as an agonist of the androgen receptor (AR), promoting muscle hypertrophy and strength gains while minimizing water retention compared to other anabolic steroids.
DHB was developed for potential use in bodybuilding and athletic performance enhancement, although it is not widely approved for medical use by regulatory agencies. Its unique properties make it appealing to athletes looking to improve their physique and performance without the significant estrogenic side effects associated with some other anabolic steroids.
Medical uses
DHB is primarily investigated for its potential applications in muscle wasting conditions and performance enhancement. While it has not received formal approval for medical use, it is often sought after in bodybuilding circles for its ability to promote lean muscle mass and improve physical performance. Its use in competitive sports is often subject to regulatory scrutiny due to its classification as an anabolic steroid.
